AZTRInvestor Conference•prnewswire•September 4, 2025 at 12:10 PM

Azitra, Inc. to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Sentiment:Negative (20)

Summary

(AZTR) BRANFORD, Conn., Sept. 4, 2025 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced that Cofounder and Chief Operating Officer, Travis Whitfill PhD MPH, will...

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on September 4, 2025 by prnewswire